CN Patent

CN107073121A — 治疗及预防癌症药物抗性的方法

Assigned to Genentech Inc · Expires 2017-08-18 · 9y expired

What this patent protects

本文提供了使用MEK拮抗剂治疗如癌症等病理病症的组合疗法。

USPTO Abstract

本文提供了使用MEK拮抗剂治疗如癌症等病理病症的组合疗法。

Drugs covered by this patent

cobimetinib-fumarate (COBIMETINIB FUMARATE)

Patent Metadata

Patent number: CN107073121A
Jurisdiction: CN
Classification: —
Expires: 2017-08-18
Drug substance claim: No
Drug product claim: No
Assignee: Genentech Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.